| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.023 | 0.9 |